Committee MemberEmploymentConsultantSpeakers BureauOwnership/Partnership/PrincipalPersonal ResearchInstitutional, Organizational, or Other Financial BenefitExpert WitnessVoting Recusals by Section
Rick A. Nishimura (Co-Chair)Mayo Clinic, Division of Cardiovascular Disease—Judd and Mary Morris Leighton Professor of MedicineNoneNoneNoneNoneNoneNoneNone
Catherine M. Otto (Co-Chair)University of Washington Division of Cardiology—Professor of MedicineNoneNoneNoneNoneNoneNoneNone
Robert O. BonowNorthwestern University Feinberg School of Medicine—Goldberg Distinguished Professor of CardiologyNoneNoneNoneNoneNoneNoneNone
Blase A. CarabelloEast Carolina University, Brody School of Medicine, East Carolina Heart Institute—Chief Cardiology DirectorNoneNoneNone
  • Edwards Lifesciences (DSMB)

  • Medtronic

None3.2.4, 7.3.3, 7.4.3, and 11.1.
John P. Erwin IIITexas A&M College of Medicine, Baylor Scott and White Health—Senior Staff Cardiologist, Clinical Professor and Chair of Internal MedicineNoneNoneNoneNoneNoneNoneNone
Lee A. FleisherUniversity of Pennsylvania, Department of Anesthesiology—Professor of AnesthesiologyNoneNoneNoneNoneNoneNoneNone
Hani JneidBaylor College of Medicine—Associate Professor of Medicine, Director of Interventional Cardiology Research; The Michael E. DeBakey VA Medical Center—Director of Interventional CardiologyNoneNoneNoneNoneNoneNoneNone
Michael J. MackThe Heart Hospital Baylor Plano—DirectorNoneNoneNoneNone
  • Abbott Vascular

  • Edwards Lifesciences

None3.2.4, 7.3.3, 7.4.3, and 11.1.
Christopher J. McLeodMayo Clinic, Division of Cardiovascular Disease—Assistant Professor of MedicineNoneNoneNoneNoneNoneNoneNone
Patrick T. O’GaraBrigham and Women’s Hospital—Professor of Medicine; Harvard Medical School—Director of Clinical CardiologyNoneNoneNoneNoneNoneNoneNone
Vera H. RigolinNorthwestern University Feinberg School of Medicine—Professor of Medicine; Northwestern Memorial Hospital—Medical Director, Echocardiography LaboratoryNoneNoneNone
  • Pfizer

NoneNoneNone
Thoralf M. Sundt IIIMassachusetts General Hospital—Chief, Division of Cardiac Surgery, Harvard Medical School—Professor of SurgeryNoneNoneNone
  • Edwards LifeSciences—Partner trial (PI)

  • Medtronic—Perigon trial (PI)

  • Thrasos (Steering Committee)

None3.2.4, 7.3.3, 7.4.3, and 11.1.
Annemarie ThompsonDuke University Medical Center—Department of Anesthesiology, Professor of Anesthesiology; Residency Program DirectorNoneNoneNoneNoneNoneNoneNone

This table represents relationships of committee members with industry and other entities that were determined to be relevant to this document. These relationships were reviewed and updated in conjunction with all meetings and/or conference calls of the writing committee during the document development process. The table does not necessarily reflect relationships with industry at the time of publication. A person is deemed to have a significant interest in a business if the interest represents ownership of ≥5% of the voting stock or share of the business entity, or ownership of ≥$5,000 of the fair market value of the business entity; or if funds received by the person from the business entity exceed 5% of the person’s gross income for the previous year. Relationships that exist with no financial benefit are also included for the purpose of transparency. Relationships in this table are modest unless otherwise noted. According to the ACC/AHA, a person has a relevant relationship IF: a) the relationship or interest relates to the same or similar subject matter, intellectual property or asset, topic, or issue addressed in the document; or b) the company/entity (with whom the relationship exists) makes a drug, drug class, or device addressed in the document or makes a competing drug or device addressed in the document; or c) the person or a member of the person's household, has a reasonable potential for financial, professional or other personal gain or loss as a result of the issues/content addressed in the document.

ACC indicates American College of Cardiology; AHA, American Heart Association; Partner, Placement of Aortic Transcatheter Valve; Perigon, Pericardial Surgical Aortic Valve Replacement; and VA, Veterans Affairs.

  • Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry and other entities may apply. Section numbers pertain to those in the full-text guideline.

  • No financial benefit.

  • Significant relationship.